Fragment-based Drug Design (FBDD) Service

Fragment-based drug design (FBDD) is a powerful approach in modern drug discovery, enabling the identification and optimization of small molecular fragments to develop high-affinity drug candidates. CD ComputaBio's fragment-based drug design service leverages advanced computational tools and expertise to accelerate the discovery of novel therapeutics. By combining cutting-edge algorithms, this service provides a comprehensive solution for fragment screening, optimization, and lead generation.

Introduction to Fragment-based Drug Design

Fragment-based drug design (FBDD) is a strategy that starts with small, low-molecular-weight compounds (fragments) and gradually builds them into potent drug candidates. Unlike traditional drug discovery methods, FBDD focuses on identifying fragments that bind weakly but specifically to target proteins. These fragments are then optimized through computational and experimental methods to enhance their binding affinity and drug-like properties. Computational tools play a critical role in FBDD, enabling the virtual screening of fragment libraries, prediction of binding modes, and optimization of fragment hits.

Figure 1. Workflow of Fragment-based Drug Design. (Li Q, 2020)

Our Services

To address the diverse challenges of fragment-based drug design, a comprehensive suite of computational services is offered, covering fragment screening, optimization, and lead generation.

Fragment Library Design

Fragment Binding Mode Prediction

Fragment Optimization and Lead Generation

Applications of Fragment-based Drug Design (FBDD)

The fragment-based drug designs offered by CD ComputaBio are applicable to a wide range of areas and drug development stages. Below are the key applications of these services:

Fragment-based drug design is a powerful and innovative approach in drug discovery, and our computational services are designed to support every aspect of this process. From generating optimized fragment libraries to identifying and optimizing lead compounds, CD ComputaBio offers a comprehensive suite of services that leverage the latest computational techniques. If you are interested in our services or have any questions, please feel free to contact us.

Reference:

1. Li Q. Application of fragment-based drug discovery to versatile targets. Frontiers in molecular biosciences, 2020, 7: 180.

• Structure-based Drug Design (SBDD) Service
• Computer Aided ADC Design Services
• Antibody De Novo Design Service
• Peptide Drug Design and Development Services
• Ligand-based Drug Design (LBDD) Service
• Multiple-Target Drug Design Services